These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 20100048

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term functional outcome after hyperthermic isolated limb perfusion (HILP).
    Knorr C, Melling N, Goehl J, Drachsler T, Hohenberger W, Meyer T.
    Int J Hyperthermia; 2008 Aug; 24(5):409-14. PubMed ID: 18608587
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hyperthermic isolation limb perfusion with TNFalpha in the treatment of in-transit melanoma metastasis.
    Di Filippo F, Rossi CR, Santinami M, Cavaliere F, Garinei R, Anzà M, Perri P, Botti C, Di Angelo P, Pasqualoni R, Di Filippo S.
    In Vivo; 2006 Aug; 20(6A):739-42. PubMed ID: 17203758
    [Abstract] [Full Text] [Related]

  • 8. Prophylactic hyperthermic limb perfusion in stage I melanoma.
    Krige JE, King HS, Strover RM.
    Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
    [Abstract] [Full Text] [Related]

  • 9. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
    Noorda EM, Vrouenraets BC, Nieweg OE, van Geel AN, Eggermont AM, Kroon BB.
    Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Isolated limb infusion as palliative treatment for advanced limb disease in patients with AJCC stage IV melanoma.
    Kroon HM, Lin DY, Kam PC, Thompson JF.
    Ann Surg Oncol; 2009 May; 16(5):1193-201. PubMed ID: 19224288
    [Abstract] [Full Text] [Related]

  • 14. Isolated limb infusion for malignant melanoma: predictors of response and outcome.
    Barbour AP, Thomas J, Suffolk J, Beller E, Smithers BM.
    Ann Surg Oncol; 2009 Dec; 16(12):3463-72. PubMed ID: 19830498
    [Abstract] [Full Text] [Related]

  • 15. Outcomes following isolated limb infusion for melanoma. A 14-year experience.
    Kroon HM, Moncrieff M, Kam PC, Thompson JF.
    Ann Surg Oncol; 2008 Nov; 15(11):3003-13. PubMed ID: 18509706
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Predictors of outcome after hyperthermic isolated limb perfusion: role of tumor response.
    Aloia TA, Grubbs E, Onaitis M, Mosca PJ, Cheng TY, Seigler H, Tyler DS.
    Arch Surg; 2005 Nov; 140(11):1115-20. PubMed ID: 16301451
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.